ADPT
Adaptive Biotechnologies CorpCompany with tickers: ADPT
CIK
1478320
CUSIP
00650F109
Shares Outstanding
160,044,392
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $70,874,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $23,623,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Operating Income | $-19,206,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Net Income | $-20,033,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Basic) | $-0.13 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Diluted) | $-0.13 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |